Home / FAM110C Knockout Cell Lines

FAM110C Knockout Cell Lines

Gene: FAM110C

Official Full Name: family with sequence similarity 110 member Cprovided by HGNC

Gene Summary: Enables alpha-tubulin binding activity. Involved in positive regulation of cell migration; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; and regulation of cell projection assembly. Located in cell cortex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO17820 FAM110C Knockout cell line (HeLa) Human FAM110C 1:3~1:6 Negative Online Inquiry
KO17821 FAM110C Knockout cell line (HCT 116) Human FAM110C 1:2~1:4 Negative Online Inquiry

Background

FAM110C Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the expression of the FAM110C gene, a crucial regulator involved in various cellular processes including growth, proliferation, and survival. These cell lines provide researchers with a powerful tool to study the functional role of FAM110C in both normal physiology and disease states.

The primary mechanism by which FAM110C knockout cell lines operate involves the disruption of the gene’s coding sequence, leading to a complete loss of protein product. This gene knockout allows for the examination of phenotypic changes, altered signaling pathways, and compensatory mechanisms that might arise in the absence of FAM110C. Researchers can utilize these cell lines to investigate the implications of FAM110C in tumorigenesis, cellular stress responses, and other pathological conditions, ultimately contributing to a more comprehensive understanding of related disease mechanisms.

The scientific importance of FAM110C knockout cell lines is particularly significant in cancer research, regenerative medicine, and developmental biology. In clinical settings, these cell lines serve as vital models for drug testing and therapeutic interventions, providing insights into potential treatment strategies and therapeutic targets.

Compared to traditional gene-editing approaches, such as CRISPR-Cas9, our FAM110C Gene Knockout Cell Lines offer stability and consistency, ensuring reproducibility in experimental results. Additionally, they allow for rapid validation of findings without the extended timeframe often associated with generating stable knockout models.

For researchers and clinicians seeking to delve deeper into the biological significance of the FAM110C gene, these knockout cell lines present a unique advantage. They enable targeted analyses and can expedite the transition of laboratory findings to potential clinical applications, making them invaluable for advancing genomic research and therapeutic development.

Our company prides itself on its commitment to providing high-quality, genetically modified models that support cutting-edge research. With a focus on scientific excellence, we strive to empower researchers with the tools necessary to unlock new discoveries in the field of molecular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.